Working… Menu
Trial record 1 of 1 for:    A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure with Iron Deficiency | Recruiting Studies
Previous Study | Return to List | Next Study

Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency (HEART-FID)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03037931
Recruitment Status : Recruiting
First Posted : January 31, 2017
Last Update Posted : August 10, 2021
Duke Clinical Research Institute
Information provided by (Responsible Party):
American Regent, Inc.